Risperdal Gynecomastia

If you or your child has suffered adverse effects after taking the drug Risperdal, you may be eligible for financial compensation.

The anti-psychotic drug Risperdal has been linked to the development of breasts in young men, a condition known as gynecomastia. Risperdal is commonly prescribed as an anti-psychotic drug to treat a variety of mental and mood disorders including schizophrenia, bi-polar disorder and irritability associated with autism. Other side effects of taking Risperdal may include pain, nipple discharge and the psychological and emotional trauma associated with the development of male breasts.

Risperdal generally causes gynecomastia by and through its active ingredient risperidone, which increases the body’s level of prolactin (a hormone that stimulates normal breast development in females). When a male takes Risperdal, he is at risk of suffering gynecomastia because of the elevated level of prolactin in his body. Elevated prolactin levels can linger for up to two years after taking the drug.

Manufactured by Johnson & Johnson and Janssen Pharmaceuticals, Risperdal was used to treat a variety of psychiatric conditions in children even before it was approved for use in treating children. Risperdal was not approved for use in children until 2006 and then for only certain conditions, yet Johnson & Johnson pushed the drug for use in children as early as 2004. (You can read a Bloomberg article by clicking here that discusses what occurred.)

Injuries caused by Risperdal has already resulted in multiple claims filed by young men suffering from gynecomastia. These claims and lawsuits allege that Johnson & Johnson failed to adequately warn young men of the risk and danger associated with taking Risperdal and the physical and psychological effects of developing breasts and other side effects.

If you, your child or someone you know took Risperdal and developed male breasts or gynecomastia, the attorneys at Burke Harvey are ready to help you understand your legal rights.